> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Revising ANDA Labeling
- URL: https://www.fdaweb.com/guide-on-revising-anda-labeling/
- Published: 2024-01-25T12:00:00.000Z
- Updated: 2026-09-14T14:21:18.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5156211

*Federal Register* notice: FDA is making available a final guidance entitled “Revising ANDA Labeling Following Revision of the RLD Labeling.” The document provides recommendations for updating ANDA labeling following revisions to the labeling of a reference-listed drug (RLD), including information on how to identify RLD labeling updates and how to submit labeling updates to both unapproved and approved ANDAs to conform to RLD labeling updates. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-01-25/pdf/2024-01442.pdf?ref=fdaweb.com).